Examining sexual dysfunction in women after rectal cancer surgery and the effects of sexologist intervention
Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention
This study looks at how many women have sexual problems after rectal cancer surgery and whether talking to a sex expert can help them feel better compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 144 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Limoges Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 6 sites (Brive-la-Gaillarde and 5 other locations) |
| Trial ID | NCT05933122 on ClinicalTrials.gov |
What this trial studies
This study aims to determine how common sexual dysfunction is among women who have undergone surgery for rectal cancer. It will assess the prevalence of these issues before treatment and analyze the impact of consultations with a sexologist on improving sexual well-being. The study will compare outcomes between women receiving sexology consultations and those receiving standard care. By focusing on female patients, it seeks to fill a gap in existing research that has primarily addressed male sexual dysfunction post-cancer treatment.
Who should consider this trial
Good fit: Ideal candidates are women over 18 diagnosed with stage I-III rectal adenocarcinoma who have undergone surgical management.
Not a fit: Patients who are currently pregnant or have significant cognitive or psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved sexual health and quality of life for women recovering from rectal cancer surgery.
How similar studies have performed: While there is limited research specifically addressing female sexual dysfunction post-rectal cancer surgery, studies on male patients have shown varying success, indicating a need for more focused investigations like this one.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women * Diagnosis of stage I-III rectal adenocarcinoma or rectosigmoid junction with anastomosis less than 15 cm from the anal margin * Surgical management, preceded or not by Radio-chemotherapy, with restoration of continuity * Age : over 18 * Proficiency in French or English Exclusion Criteria: * Current pregnancy * Significant cognitive/psychiatric disorders * Guardianship
Where this trial is running
Brive-la-Gaillarde and 5 other locations
- Brive Hospital — Brive-la-Gaillarde, France (Recruiting)
- Les cedres Clinical — Brive-la-Gaillarde, France (Recruiting)
- Gueret Hospital — Guéret, France (Recruiting)
- Chenieux clinical — Limoges, France (Not_yet_recruiting)
- Limoges University Hospital — Limoges, France (Recruiting)
- Saint Junien Hospital — Saint-Junien, France (Recruiting)
Study contacts
- Study coordinator: Niki Christou, MD
- Email: christou.niki19@gmail.com
- Phone: +335 55 05 67 30
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.